JAVMA news
All hydrocodone products now schedule II drugs
The Drug Enforcement Administration has scheduled all hydrocodone-containing products as schedule II drugs
JAVMA news
Companies to reduce antimicrobial availability
Hundreds of antimicrobial products will no longer be approved for livestock production uses, such as increased weight gain
JAVMA news
FDA clarifies use of monensin
Rumensin is the first approved new animal drug feed ingredient for dairy cows that increases milk production.
JAVMA news
Cattle veterinarians honored
Seven veterinarians received awards in September for their contributions to bovine medicine.
JAVMA news
The ProHeart debate
In January, the Food and Drug Administration's Veterinary Medicine Advisory Committee and consultants heard presentations
JAVMA news
Changes coming in antimicrobial use, availability
When the types of antimicrobials important for human medicine are sold for use in farm animals, only a small portion require a
JAVMA news
Drug-related positions approved
The Executive Board approved two new position statements, three revised positions, and rescission of an existing position
JAVMA news
FDA’s Dunham delves into drug issues
Dr. Bernadette Dunham, director of the Food and Drug Administration’s Center for Veterinary Medicine, recently fielded questions about drug issues and…
JAVMA news
Reminder: extralabel drug use of sulfonamides in lactating dairy cattle prohibited
The Food and Drug Administration's Center for Veterinary Medicine reminds veterinarians that extralabel use of sulfonamides is prohibited.
JAVMA news
Internet drug sales to U.S. pet owners questioned
The AVMA occasionally receives questions from veterinarians who believe their clients have purchased—without their
JAVMA news
Tramadol becomes controlled substance
The Drug Enforcement Administration has designated tramadol as a controlled substance
JAVMA news
Revised guide to drug, vaccine, pesticide use in aquaculture available
The revised edition of the popular Guide to Drug, Vaccine, and Pesticide Use in Aquaculture is now available as a Web document
JAVMA news
Move follows AABP conference
The American Association of Bovine Practitioners moved its headquarters from Georgia to Alabama
JAVMA news
Compounding Resources will educate veterinary profession
In recent months, the Food and Drug Administration has been cracking down on illegal drug compounding.
Your Pet's Medications
Provides basic information for pet owners about pet medications and their safe use.
JAVMA news
When can a veterinarian import a foreign drug?
NOTE: Please see Oct. 15, 2009, JAVMA News article, "FDA no longer issuing letters for importation for unapproved animal drugs," for…
JAVMA news
Ruling gives FDA discretion in drug withdrawals
An appellate court overturned a ruling that would have made federal drug authorities start proceedings to withdraw some antimicrobial uses in…
JAVMA news
Gaining weight
Pre-slaughter weights of livestock species have been increasing since at least the 1920s, and some of the largest gains have occurred in the past 25…
JAVMA news
FDA stops use of enrofloxacin for bacterial infections in poultry
The Food and Drug Administration announced it would no longer allow distribution or use of the antimicrobial enrofloxacin after
JAVMA news
Cattle veterinarians wanted
About 5,000 veterinarians are members of the American Association of Bovine Practitioners, but that’s still likely less than a third of all…
JAVMA news
Expanding, adapting cattle practice
An acting instructor told cattle veterinarians to show energy and passion in their business conversations with clients and colleagues.
JAVMA news
Riddell named to lead AABP
Dr. M. Gatz Riddell Jr. was named to the position by the AABP board of directors Feb. 12 during a special meeting in Atlanta.
JAVMA news
Substitution errors
Ten percent of veterinarians responding to recent polls said they have had patients harmed when outside pharmacies made substitutions in filling…
JAVMA news
Battles over compounding from bulk drugs move forward
Animal drug compounding from bulk drug substances has become a heated issue since the Food and Drug Administration